Chronic cough associated with interferon/ribavirin therapy for hepatitis C.

about

Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin.ACE inhibitors and ribavirin-associated cough: a common undefined predisposing factor?

P2860

Q45352196-2E748EA2-A665-402A-9158-4D2653C9ED5E Q50551028-6D703242-8782-4996-8441-ED19B623DE5C

P2860

Chronic cough associated with interferon/ribavirin therapy for hepatitis C.

Item

http://www.wikidata.org/entity/Q43036519

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Chronic cough associated with interferon/ribavirin therapy for hepatitis C.

@en

Chronic cough associated with interferon/ribavirin therapy for hepatitis C.

@nl

type

Item

label

Chronic cough associated with interferon/ribavirin therapy for hepatitis C.

@en

Chronic cough associated with interferon/ribavirin therapy for hepatitis C.

@nl

prefLabel

Chronic cough associated with interferon/ribavirin therapy for hepatitis C.

@en

Chronic cough associated with interferon/ribavirin therapy for hepatitis C.

@nl

P1476

Chronic cough associated with interferon/ribavirin therapy for hepatitis C.

@en

P2093

F R Weiner

http://www.w3.org/2001/XMLSchema#string

P V Dicpinigaitis

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of adding ribavirin to interferon to treat chronic hepatitis C infection: a systematic review and meta-analysis of randomized trials.

Pneumonitis as a consequence of (peg)interferon-ribavirin combination therapy for hepatitis C: a review of the literature

Safety of capsaicin cough challenge testing.

Experimentally induced cough.

Peginterferon and ribavirin for chronic hepatitis C.

TRPV1 antagonists as potential antitussive agents.

TRPA1: a potential target for anti-tussive therapy.

Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro.

Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.

P304

416-418

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2710.2010.01182.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21545621

http://www.w3.org/2001/XMLSchema#string

Chronic cough associated with interferon/ribavirin therapy for hepatitis C.

about

P2860

P2860

Chronic cough associated with interferon/ribavirin therapy for hepatitis C.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698